Skip to content
Clinical Trials – home

Posaconazole: A Comprehensive Guide for Patients

8 / 11
trials open to patients / all trials
10+
Countries

In short

This article explores the use of posaconazole, an antifungal medication, in clinical trials for the prevention and treatment of invasive fungal infections. Posaconazole, also known by its brand name Noxafil, has been studied in various formulations including oral suspension, tablets, and intravenous solutions. The trials aim to evaluate its efficacy, safety, and pharmacokinetics in different patient populations at high risk for fungal infections.

At a glance

Drug Formulations
Oral suspension, tablets, intravenous solution
Primary Uses
Prevention and treatment of invasive fungal infections
Target Populations
Patients with acute myeloid leukemia, myelodysplastic syndrome, stem cell transplant recipients, those with graft-versus-host disease
Dosing Regimens
Varied across trials, e.g., 100-400 mg daily for 12-24 weeks
Efficacy Measures
Complete cure, effective treatment, treatment success rates
Safety Assessments
Adverse events, laboratory values, vital signs
Pharmacokinetic Parameters
Plasma concentration, AUC, Cmax, Cmin, Tmax, clearance
Special Considerations
Impact of mucositis on absorption, comparison with other antifungals (e.g., terbinafine)

What is Posaconazole?

Posaconazole, also known by its brand name Noxafil, is an antifungal medication used to prevent and treat various fungal infections. It belongs to a class of drugs called azole antifungals. Posaconazole is sometimes referred to by its research names SCH 56592 or MK-5592.

What Conditions Does Posaconazole Treat?

Posaconazole is used to treat or prevent several fungal infections, including:

  • Invasive Aspergillosis: A serious fungal infection that primarily affects the lungs but can spread to other organs.
  • Fungal infections in patients with weakened immune systems: This includes patients undergoing chemotherapy for leukemia or stem cell transplantation.
  • Onychomycosis: A fungal infection of the toenails, although this is not its primary use.
  • Chagas disease: While primarily an antiparasitic treatment, posaconazole has been studied for use in this condition.

How Does Posaconazole Work?

Posaconazole works by blocking the production of ergosterol, an essential component of fungal cell membranes. By disrupting the fungal cell membrane, posaconazole effectively stops the growth and spread of fungal infections.

Available Formulations

Posaconazole is available in several formulations to suit different patient needs:

  • Oral suspension: A liquid form that can be taken by mouth.
  • Tablets: A solid oral form that may be easier for some patients to take.
  • Intravenous (IV) infusion: A form that is given directly into the bloodstream, usually in hospital settings.

Dosage and Administration

The dosage of posaconazole varies depending on the formulation and the condition being treated. Some common dosing regimens include:

  • Oral suspension: Typically 200-400 mg taken 2-3 times daily with food.
  • Tablets: Usually 300 mg taken twice daily on the first day, then 300 mg once daily.
  • IV infusion: Often 300 mg twice daily on the first day, then 300 mg once daily, infused over 90 minutes.

It's important to note that dosages may be adjusted based on individual patient factors and the specific condition being treated. Always follow your healthcare provider's instructions.

Efficacy of Posaconazole

Clinical trials have shown posaconazole to be effective in preventing and treating various fungal infections. For example:

  • In patients with acute myeloid leukemia or myelodysplastic syndrome undergoing chemotherapy, posaconazole was effective in preventing invasive fungal infections.
  • Studies have shown promising results in treating onychomycosis (toenail fungal infections), with various dosing regimens showing different levels of effectiveness.
  • Research is ongoing to evaluate posaconazole's effectiveness in treating Chagas disease, a parasitic infection.

Potential Side Effects

Like all medications, posaconazole can cause side effects. Common side effects may include:

  • Nausea or vomiting
  • Diarrhea
  • Headache
  • Abdominal pain
  • Fever

More serious side effects, though rare, can occur. These may include liver problems or heart rhythm changes. It's important to report any unusual symptoms to your healthcare provider.

Special Considerations

Several factors can affect how posaconazole works in your body:

  • Food intake: The oral suspension form of posaconazole should be taken with food or a nutritional supplement to improve absorption.
  • Mucositis: This condition, which involves inflammation of the digestive tract lining, may affect the absorption of oral posaconazole. In such cases, the IV form might be preferred.
  • Inflammation: Research is ongoing to understand how inflammation in the body might affect posaconazole levels.
  • Drug interactions: Posaconazole can interact with other medications. Always inform your healthcare provider about all medications you're taking.

Questions people often ask

Conditions where Posaconazole is being studied

Each condition opens its own overview and trial list

Trials with Posaconazole

Recruiting trials first

See all 11 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.